Skip to main content
SpringerLink
Log in

Systemic inflammation in nonischemic dilated cardiomyopathy

  • Short Communication
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

We investigated links between inflammatory systemic activation and clinical presentation of nonischemic dilated cardiomyopathy (NIDC). Thirty-one consecutive patients with NIDC (age 57 ± 10 years, left ventricular ejection fraction 32% ± 7%) were enrolled in the study: subjects with ischemic heart disease, valvular heart disease, congenital malformations, pulmonary, renal, inflammatory, or metabolic diseases were excluded. All patients underwent physical examination, electrocardiography, chest radiology, echocardiography, and coronary angiography. Plasma levels of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and fibrinogen were ascertained. New York Heart Association (NYHA) functional class was significantly correlated with concentrations of fibrinogen (r = 0.42, P < 0.05) and CRP (r = 0.52, P < 0.01), and with ESR (r = 0.46, P < 0.05). Left ventricular ejection fraction was inversely related to fibrinogen (r = −0.41, P < 0.05) and ln CRP (r = −0.46, P < 0.05). Correlations between NYHA class and markers of inflammation remained significant also after correction for age, sex, and cardiovascular risk factors. Ongoing treatment with statins was associated with reduced CRP levels. Inflammatory markers are increased in patients with NIDC proportionally with severity of symptoms and systolic impairment. Systemic inflammation might be related to deterioration of NYHA class.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yin WH, Chen JW, Jen HL, Chiang MC, Huang WP, Feng AN, Young MS, Lin SJ (2004) Independent prognostic value of elevated high sensitivity C-reactive protein in chronic heart failure. Am Heart J 147:931–938

    Article  PubMed  CAS  Google Scholar 

  2. Sharma R, Rauchhaus M, Ponikowski PP, Varney S, Poole-Wilson PA, Mann DL, Coats AJS, Anker SD (2000) The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 6:523–528

    Article  Google Scholar 

  3. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M (2003) Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 108: 2317–2322

    Article  PubMed  CAS  Google Scholar 

  4. Sampietro T, Neglia D, Bionda A, Dal Pino B, Bigazzi F, Puntoni M, Startari U, Morales A, Minichilli F, Bianchi F, L’Abbate A (2005) Inflammatory markers and serum lipids in idiopathic dilated cardiomyopathy. Am J Cardiol 96:1718–1720

    Article  PubMed  CAS  Google Scholar 

  5. Kaneko K, Kanda T, Yamauchi Y, Hasegawa A, Iwasaki T, Arai M, Suzuki T, Kobayashi I, Nagai R (1999) C-reactive protein in dilated cardiomyopathy. Cardiology 91:215–219

    Article  PubMed  CAS  Google Scholar 

  6. Lamparter S, Grimm W (2005) Predictive value of high-sensitivity C-reactive protein in patients with idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol. 28Suppl 1:S233–S236

    Article  PubMed  Google Scholar 

  7. Calabrò P, Willerson JT, Yeh ET (2003) Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108:1930–1932

    Article  PubMed  CAS  Google Scholar 

  8. Gould JM, Weiser JN (2001) Expression of C-reactive protein in the human respiratory tract. Infect Immun 69:1747–1748

    Article  PubMed  CAS  Google Scholar 

  9. Jabs WJ, Logering BA, Gerke P, Kreft B, Wolber EM, Klinger MH, Fricke L, Steinhoff J (2003) The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol 33:152–161

    Article  PubMed  CAS  Google Scholar 

  10. Yasojima K, Schwab C, McGeer EG, McGeer PL (2000) Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer’s disease. Brain Res 887:80–89

    Article  PubMed  CAS  Google Scholar 

  11. Nijmeijer R, Lagrand WK, Lubbers YT, Visser CA, Meijer CJ, Niessen HW, Hack CE (2003) C-reactive protein activates complement in infarcted human myocardium. Am J Pathol 163:269–275

    PubMed  CAS  Google Scholar 

  12. Satoh M, Nakamura M, Akatsu T, Shimoda Y, Segawa I, Hiramori K (2005) C-reactive protein co-expresses with tumor necrosis factor-alpha in the myocardium in human dilated cardiomyopathy. Eur J Heart Fail 7:748–754

    Article  PubMed  CAS  Google Scholar 

  13. Ikeda U, Maeda Y, Yamamoto K, Shimada K (2002) C-reactive protein augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. Cardiovasc Res 56:86–92

    Article  PubMed  CAS  Google Scholar 

  14. Pasceri V, Chang J, Willerson JT, Yeh ETH (2001) Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103:2531–2534

    PubMed  CAS  Google Scholar 

  15. Choi H, Cho DH, Shin HH, Park JB (2004) Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension. Circ J 68:628–633

    Article  Google Scholar 

  16. Ishikawa C, Tsutamoto T, Fujii M, Sakai H, Tanaka T, Horie M (2006) Prediction of mortality by high-sensitivity C-reactive protein and brain natriuretic peptide in patients with dilated cardiomyopathy. Circ J 70:857–863

    Article  PubMed  CAS  Google Scholar 

  17. Fukunaga T, Soejima H, Irie A, Sugamura K, Oe Y, Tanaka T, Nagayoshi Y, Kaikita K, Sugiyama S, Yoshimura M, Nishimura Y, Ogawa H (2007) Relation between CD4+ T-cell activation and severity of chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 100:483–488

    Article  PubMed  CAS  Google Scholar 

  18. Fukunaga T, Soejima H, Irie A, Sugamura K, Oe Y, Tanaka T, Kojima S, Sakamoto T, Yoshimura M, Nishimura Y, Ogawa H (2007) Expression of interferon-gamma and interleukin-4 production in CD4+ T cells in patients with chronic heart failure. Heart Vessels 22:178–183

    Article  PubMed  Google Scholar 

  19. Sánchez-Lázaro IJ, Almenar L, Reganon E, Vila V, Martínez-Dolz L, Martínez-Sales V, Moro J, Agüero J, Ortiz-Martínez V, Salvador A (2007) Inflammatory markers in stable heart failure and their relationship with functional class. Int J Cardiol [Epub ahead of print]

  20. Abou-Raya S, Abou-Raya A, Naim A, Abuelkheir H (2007) Chronic inflammatory autoimmune disorders and atherosclerosis. Ann N Y Acad Sci 1107:56–67

    Article  PubMed  CAS  Google Scholar 

  21. Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, Goldstein S (1989) Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol 14: 564–570

    Article  PubMed  CAS  Google Scholar 

  22. Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KS, Banerjee A, Harken AH (1999) Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med 27:1309–1318

    Article  PubMed  CAS  Google Scholar 

  23. Tsutamoto T, Hisanaga T, Wada A, Maeda K, Ohnishi M, Fukai D, Mabuchi N, Sawaki M, Kinoshita M (1998) Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 31:391–398

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiology Department, University of Foggia, viale L. Pinto 1, 71100, Foggia, Italy

    Luisa De Gennaro, Natale Daniele Brunetti, Andrea Cuculo, Pier Luigi Pellegrino & Matteo Di Biase

Authors
  1. Luisa De Gennaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Natale Daniele Brunetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea Cuculo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pier Luigi Pellegrino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Matteo Di Biase
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Natale Daniele Brunetti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Gennaro, L., Brunetti, N.D., Cuculo, A. et al. Systemic inflammation in nonischemic dilated cardiomyopathy. Heart Vessels 23, 445–450 (2008). https://doi.org/10.1007/s00380-008-1075-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-008-1075-4

Key words

Search

Navigation